Industry News

• Bruker and Agilent announce agreement for Bruker to acquire certain Varian products  Bruker and Agilent Technologies announced that Bruker and Agilent have entered into a definitive asset purchase agreement. Bruker will acquire certain product lines of Varian, which Agilent has committed to divest.
  Bruker Corporation March 09, 2010  
• Abbott enhances pharmaceutical pipeline with acquisition of Facet Biotech  Abbott and Facet Biotech announced a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.
  Abbott March 09, 2010  
• FDA Advisory Committee recommends approval of InterMune's Esbriet(R) (pirfenidone) for IPF  InterMune announced that the U.S. Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 9-3 to recommend approval of Esbriet(R) (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.
  InterMune, Inc. March 09, 2010  
• Vaccinating children against flu helps protect wider community  Results of a clinical trial conducted in a largely self-contained religious community during the 2008-09 influenza season show that immunizing children against seasonal influenza can significantly protect unvaccinated community members against influenza as well.
  National Institutes of Health March 09, 2010  
• InSite Vision reports full year and fourth quarter 2009 financial results  Revenues for the year ended December 31, 2009 were $9.8 million compared to $13.7 million for the same period in 2008. 2009 revenues included royalties from Inspire Pharmaceuticals of $8.0 million for sales of AzaSite compared to $3.6 million in 2008.
  InSite Vision Incorporated March 09, 2010  
• ACADIA Pharmaceuticals reports financial results for the fourth quarter and year  ACADIA reported a net loss of $8.7 million, or $0.23 per common share, for the fourth quarter of 2009 compared to a net loss of $14.0 million, or $0.38 per common share, for the fourth quarter of 2008.
  ACADIA Pharmaceuticals, Inc. March 09, 2010  
• Presentation by Lowell Parsons, MD now on Urigen.com  Urigen Pharmaceuticals announced that video of the recent presentation made by Prof. Lowell Parsons in Atlanta on February 25th, 2010 is now available at www.urigen.com.
  Urigen Pharmaceuticals, Inc. March 09, 2010  
• Bristol-Myers Squibb and AstraZeneca announce the commencement of the SAVOR-TIMI 53  BMS and AstraZeneca announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial (SAVOR-TIMI 53), a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA(TM)(saxagliptin).
  Bristol-Myers Squibb Company March 09, 2010  
• Cardium reports on registered direct offering  Cardium Therapeutics announced that it has entered into agreements with certain institutional investors to sell $5.0 million out of its proposed $10 million registered direct offering.
  Cardium Therapeutics, Inc. March 09, 2010  
• Monsanto to break ground on new breeding station in Mississippi  To better serve the needs of southern farmers, Monsanto plans to open a new corn breeding station in Flora, Mississippi. The $2.4 million facility further boosts the company's investment in the South and is a reflection of Monsanto's commitment to continue delivering new high-performing products.
  Monsanto Company March 09, 2010  

   (next 10 articles)